The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2025

Filed:

Nov. 19, 2021
Applicant:

Stembiosys, Inc., San Antonio, TX (US);

Inventors:

Travis Block, San Antonio, TX (US);

Edward S. Griffey, San Antonio, TX (US);

Todd Herron, New Hudson, MI (US);

Assignee:

STEMBIOSYS, INC., San Antonio, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/077 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0657 (2013.01); G01N 33/5061 (2013.01); C12N 2503/02 (2013.01); C12N 2506/45 (2013.01); C12N 2533/52 (2013.01); C12N 2533/54 (2013.01); C12N 2533/90 (2013.01);
Abstract

Disclosed are methods of using a cell-derived extracellular matrix derived in-vitro from cells isolated from amniotic fluid (AFC-ECM) for the maturation of immature cardiomyocytes derived from human induced pluripotent stem cells (immature hiPSC-CMs) in culture forming mature cardiomyocytes. Also disclosed is a cell construct comprising a monolayer of these mature cardiomyocytes on an AFC-ECM useful for cardiotoxicity and/or proarrhythmic screening assays of drug compounds. Also disclosed are methods for determining the cardiotoxicity and/or proarrhythmic effect of a drug compound in vitro using such cell constructs.


Find Patent Forward Citations

Loading…